DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA506652
Title:
Inflammation, Prostate Cancer and Negative Regulation of Androgen Receptor Expression
Descriptive Note:
Annual summary rept.
Corporate Author:
TEXAS UNIV HEALTH SCIENCE CENTER AT SAN ANTONIO
Report Date:
2009-05-01
Pagination or Media Count:
25.0
Abstract:
My study involved two aspects of androgen receptor AR regulation-1 molecular mechanism underlying negative regulation of AR expression and activity, 2 microRNA-mediated regulation of prostate cancer cell proliferation. My data establish that the human AR level is negatively regulated by nuclear factor kB NF-kB following its activation by TNF-alpha-induced signaling. I have defined the regulatory region in the human AR promoter that responds to the TNF-alpha-controlled negative transcriptional regulation. I show that TNF-alpha-controlled inhibition of AR expression occurs in androgen-dependent LNCaP human prostate cancer cells, but not in the androgen-independent C4-2 human prostate cancer cells. I further show that TNF-alpha treatment caused recruitment of corepressor complexes on negative response region in LNCaP cells, but not in C4-2 cells. To search for the microRNA effect on prostate cancer, scanning of the cancer microRNA array shows that miR-454 is up regulated in androgen-independent C4-2 cells and overexpression of miR-454 enhanced prostate cancer cell proliferation. In addition, Slain1 is identified as a miR-454 target protein using bioinformatics approaches.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE